Company
Investment-firm
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Contacts
Similar Companies133
GBS Ventures
GBS Venture Partners invests in innovative businesses improving patients' lives and generating returns.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Hopen Life Science Ventures
Hopen Life Science Ventures is a venture capital firm focused on life sciences.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Pappas Capital
Pappas Capital invests in life science companies across the United States and Canada.
Sector
Subsector
Location
count Of Investments
count Of Exists
Primer Capital
Primer Capital is a venture capital firm in Moscow City that focuses on investing in biotech and medical companies.
Sector
Subsector
Keywords
Location
count Of Investments
Financials
Investments71
Marea Therapeutics
Marea is a biotechnology firm that uses the advancements in human genetics next-generation medications for cardiometabolic illnesses.
total rounds
total raised
Attovia Therapeutics
Attovia Therapeutics is developing biotherapeutics for immune-mediated diseases, with a particular focus on cancer.
Sector
Subsector
Keywords
Location
total rounds
total raised
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals develops innovative therapeutics for rare and age-related diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Co-Investors
Exits5
Seragon Pharmaceuticals
Seragon Pharmaceuticals is a research-based biopharmaceutical company.
Sector
Subsector
Location
total rounds
total raised
Turning Point Therapeutics
Turning Point Therapeutics is developing investigational drugs to overcome limitations of existing cancer therapies.
Sector
Subsector
Keywords
Location
total rounds
total raised
Labrys Biologics
Labrys Biologics Inc. is a company specialising in treatments for chronic migraine.
Sector
Subsector
Location
total rounds
total raised
People
Founders3
Robert Adelman
Robert J. Adelman, also known as Rob, M.D., is a co-founder of venBio LLC and serves as its Managing Director, Managing Partner and Partner. Robert Adelman has 30 year history of founding, investing in, and managing companies in the life sciences. Prior to that, Robert Adelman was a Partner at OrbiMed Advisors, L.L.C. At OrbiMed, he was part of a team that invested $1.1 billion in both public and private companies across three venture capital funds. Robert Adelman's focus was on private equity investments and structured transactions of small-capitalization public equity companies. Prior to joining OrbiMed, he served as the Vice President of Business Development at NeoGenesis Pharmaceuticals, Inc. Prior to his tenure with NeoGenesis, Robert Adelman founded Veritas Medicine, Inc. Robert Adelman co-founded Qiagen Operon, Inc. He has founded a number of biotechnology companies, including Sientra, Inc. and Roka Bioscience. As a Practicing Orthopedic Surgeon, he was involved with major implant manufacturers on hip and knee replacement design. Robert Adelman has been a Director of Innovative Spinal Technologies, Inc. since August 2, 2005. He serves as a Director of Precision BioSciences, Inc. since May 11, 2015. He has been a Director at HMBL Limited (formerly Heart Metabolics Limited) since April 2014. Robert Adelman has been an Independent Director at Seragon Pharmaceuticals Inc. since October 2012. He serves as a Director of ViewRay, Inc. and Solstice Biologics LLC. He served as a Member of the Board of Directors of Aragon Pharmaceuticals, Inc. and Sientra, Inc. Robert Adelman served as a Director of ARYx Therapeutics, Inc. from July 2002 to February 5, 2009 and CryoCor, Inc. from June 2003 to May 14, 2007. He served as an Independent Director at Volcano Corporation from February 2005 to June 7, 2007. He served as a Director of Cerimon Pharmaceuticals, Inc. He was trained as an Orthopedic Surgeon at the Hospital for Special Surgery at Cornell University. Robert Adelman received M.D. from Yale University School of Medicine and A.B. in Biochemistry with highest Honors from the University of California, Berkeley performed his residency at Cornell University Medical Center, and practiced surgery in New York and New Jersey.
current job
Robert Adelman
Corey Goodman
Corey Goodman is a renowned scientist, entrepreneur, educator, CEO, and corporate executive. Goodman is Founding Partner of venBio, Adjunct Professor at the University of California, San Francisco, and Chair of the Board of Directors of Limerick BioPharma, Second Genome, Oligasis, and Ossianix, and member of the Board of NeuroTherapeutics Pharma. He is an elected member of the National Academy of Sciences, the American Academy of Arts and Sciences, and the American Philosophical Society. Goodman was previously President of Pfizer's Biotherapeutics and Bioinnovation Center and a member of its Executive Leadership Team. He is a co-founder of Exelixis, Renovis, and Second Genome, and served as CEO of Renovis prior to its acquisition. Goodman is also a member of the California Council on Science and Technology, the Pacific Institute, the Board of the McKnight Endowment Fund for Neuroscience, BayBio, Biotechnology Institute, Bay Area Science and Innovation Consortium, New York Stem Cell Foundation, QB3 (UCSF-UCB-UCSC) Industry Advisory Board, Stanford's BioX Biosciences Advisory Council, Spinal Muscular Atrophy Foundation, and is former Chair of the National Research Council's Board on Life Sciences. During his academic career, Goodman spent over two decades as a professor of biology and neuroscience at Stanford and U.C. Berkeley, and earning numerous scientific awards such as the Alan T. Waterman Award from the National Science Board, the Gairdner International Award for Achievement in Medical Sciences, and the March-of-Dimes Prize in Developmental Biology. Goodman received his B.S. from Stanford University, Ph.D. from U.C. Berkeley, and was a postdoctoral fellow at U.C. San Diego.
current job
count Of Investments
Corey Goodman
Employee Profiles9
Activity
Recent News12
The graph reveals the ratio (%) of positive news articles in a chosen time range